We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$17.9B
AUM Growth
+$1.14B
(+6.8%)
Cap. Flow
+$898M
Cap. Flow
% of AUM
5.03%
Top 10 Holdings %
Top 10 Hldgs %
20.79%
Holding
1,733
New
108
Increased
875
Reduced
669
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$31.3M |
| 2 |
Amazon
AMZN
|
+$30.2M |
| 3 |
A.O. Smith
AOS
|
+$28.2M |
| 4 |
3M
MMM
|
+$25M |
| 5 |
AbbVie
ABBV
|
+$24.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Compass Minerals
CMP
|
+$11.7M |
| 2 |
Bank of Marin Bancorp
BMRC
|
+$10.6M |
| 3 |
FLIC
First of Long Island Corp
FLIC
|
+$9.9M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$9.26M |
| 5 |
Cincinnati Financial
CINF
|
+$9.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.26% |
| 2 | Financials | 12.67% |
| 3 | Consumer Staples | 11.59% |
| 4 | Industrials | 11.46% |
| 5 | Healthcare | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
1501
DELISTED
Immunogen Inc
IMGN
| $138K | ﹤0.01% |
57,096
-1,754
| -3% | -$4.66K |
|
|
CCXI
1502
DELISTED
ChemoCentryx, Inc.
CCXI
| $138K | ﹤0.01% |
20,407
+1,088
| +6% | +$8.17K |
|
|
LTHM
1503
DELISTED
Livent Corporation
LTHM
| $136K | ﹤0.01% |
20,403
+379
| +2% | +$2.55K |
|
|
CBAY
1504
DELISTED
Cymabay Therapeutics
CBAY
| $135K | ﹤0.01% |
26,444
+84
| +0.3% | +$509 |
|
|
MNDT
1505
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $135K | ﹤0.01% |
+10,097
| New | +$143K |
|
|
FOE
1506
DELISTED
Ferro Corporation
FOE
| $135K | ﹤0.01% |
11,371
+206
| +2% | +$2.61K |
|
|
BPFH
1507
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $135K | ﹤0.01% |
11,573
+343
| +3% | +$3.86K |
|
|
ODP
1508
DELISTED
ODP
ODP
| $134K | ﹤0.01% |
7,636
+223
| +3% | +$3.84K |
|
1509
Aurinia Pharmaceuticals
AUPH
$1.97B
| $133K | ﹤0.01% |
24,850
-1,979
| -7% | -$12K |
|
|
FG
1510
DELISTED
FGL Holdings Ordinary Shares
FG
| $133K | ﹤0.01% |
16,612
+1,087
| +7% | +$8.64K |
|
1511
3D Systems Corp
DDD
$420M
| $131K | ﹤0.01% |
16,094
+1,179
| +8% | +$9.51K |
|
1512
MediciNova
MNOV
$65M
| $131K | ﹤0.01% |
16,426
-367
| -2% | -$3.27K |
|
|
TIVO
1513
DELISTED
Tivo Inc
TIVO
| $131K | ﹤0.01% |
17,152
+773
| +5% | +$5.91K |
|
1514
Dianthus Therapeutics
DNTH
$5.68B
| $130K | ﹤0.01% |
793
-5
| -0.6% | -$950 |
|
|
AVYA
1515
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $130K | ﹤0.01% |
12,684
+1,535
| +14% | +$18K |
|
|
ADVM
1516
DELISTED
Adverum Biotechnologies
ADVM
| $129K | ﹤0.01% |
2,360
-68
| -3% | -$7.66K |
|
|
DCH
1517
Dauch Corp
DCH
$1.3B
| $129K | ﹤0.01% |
15,704
+554
| +4% | +$5.03K |
|
|
DERM
1518
DELISTED
Dermira, Inc.
DERM
| $129K | ﹤0.01% |
20,110
+747
| +4% | +$6.24K |
|
1519
CytomX Therapeutics
CTMX
$705M
| $128K | ﹤0.01% |
17,365
-575
| -3% | -$5.67K |
|
1520
Magnolia Oil & Gas
MGY
$6B
| $128K | ﹤0.01% |
+11,513
| New | +$124K |
|
1521
O-I Glass
OI
$1.39B
| $128K | ﹤0.01% |
12,464
-729
| -6% | -$9.4K |
|
1522
Conduent
CNDT
$230M
| $124K | ﹤0.01% |
+19,872
| New | +$154K |
|
|
QEP
1523
DELISTED
QEP RESOURCES, INC.
QEP
| $124K | ﹤0.01% |
33,441
+1,058
| +3% | +$5.04K |
|
|
FSP
1524
Franklin Street Properties
FSP
$44.8M
| $123K | ﹤0.01% |
14,539
+413
| +3% | +$3.24K |
|
1525
BioCryst Pharmaceuticals
BCRX
$2.37B
| $122K | ﹤0.01% |
42,441
-1,314
| -3% | -$4.09K |
|
Similar funds
ProShare Advisors's Q3 2019 Portfolio in Review
As of Q3 2019, ProShare Advisors held 1,733 positions worth $17.9B, up 6.8% from $16.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $898M of net new capital in Q3 2019, opening 108 new positions and adding to 875 existing holdings. Its largest new stake was Westwood Holdings Group: 398,825 shares worth $11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Staples.
On the sell side, the largest reduction was Compass Minerals, an estimated $11.7M trimmed.
- ProShare Advisors's largest Q3 2019 buy was Westwood Holdings Group: 398,825 shares worth $11M.
- ProShare Advisors added most to Microsoft in Q3 2019, an estimated $31.3M increase.
- ProShare Advisors's biggest Q3 2019 reduction was Compass Minerals, cutting an estimated $11.7M.
- ProShare Advisors fully exited Bank of Marin Bancorp in Q3 2019, selling an estimated $10.6M.
- ProShare Advisors's ten largest holdings make up 21% of its $17.9B portfolio in Q3 2019.
- ProShare Advisors opened 108 new positions and closed 77 in Q3 2019.
- ProShare Advisors's portfolio value rose 6.8% quarter-over-quarter to $17.9B.
Based on ProShare Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.